出处
《中国人兽共患病学报》
CAS
CSCD
北大核心
2009年第10期1000-1003,共4页
Chinese Journal of Zoonoses
基金
国家"十一五"重大传染病防治科技重大专项"结核病传播模式(结核病分子流行病学研究
2008ZX100/03-010-02"的资助
参考文献25
-
1De Rossi E, Ainsa JA,and Riccardi G. Role of myeobacterial efflux transporters in drug resistance: an unresolved question[J]. FEMS Microbiology Review, 2005,30 (1) : 36-52.
-
2Li Xian-zhi, Zhang Li, Nikaido H. Efflux pump medicated intrinsic drug resistance in Mycobacterium smegmatis [J]. Antimicrobial Agents and Chemotherapy, 2004,48 (7) : 2415-2423.
-
3Takif H E, Cimino M, Musso M. C, et al. Efflux pumps of the proton antiporter family confers to low-level fluoroquinolone resistance in mycobacterium smegmatis [J]. Proc Natl Acad Sci USA. 1996,93(1) :362-366.
-
4Liu J, Takiff H E, Nikaido H. Active efflux of fluoroquinolones in Mycobacterium smegmatis medicated by LfrA, a multildrug efflux pump(J). Journal of Bacteriology, 1996,178(13) : 3791-3795.
-
5Sander P, De Rossi E, Boddinghaus B, et al. Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance(J). FEMS Microbiology Letters, 2000,193 ( 1 ): 19-23.
-
6De Rossi E,Arrigo P, BeUinzoni M,et al. The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis [J]. Molecular Medicine, 2002,8 ( 11 ) : 714-724.
-
7Doran JL, Pang Y, Mdluli KE,et al. Mycobacterium tuberculosis efpA encodes an efflux protein of the QacA transporter family (J). Clinical Diagnostic Laboratory Immunology, 1997, 4 ( 1 ): 23-32.
-
8Silva PE A, Bigi F, Ainsa JA, et al. Characterization of P55, a multidrug efflux pump in Mycobacterium boris and Mycobacteritun tuberculosis [J]. Antimicrobial Agents and Chemotherapy, 2001,45(3): 800-804.
-
9Xin Jiang, Wenhong Zhang, Ying Zhang. Assessment of Efflux Pump Gene Expression in a Clinical Isolate Mycobacterium tuberculosis by Real-Time Reverse Transcription PCR(J). MICROBIAL DRUG RESISTANCE, 2008,14(1) :7-11.
-
10Ainsa JA, Blokpoel MC J, Otal I, et al. Molecular cloning and characterization of Tap,a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis[J]. Journal of Bacteriology,1998,180(22) :5836-5843.
同被引文献16
-
1张慧洁,陈兰举,陈名武.T淋巴细胞亚群在结核感染免疫反应中的作用[J].实用儿科临床杂志,2006,21(19):1342-1343. 被引量:23
-
2Bay DC,Turner RJ. Diversity and evolution of the small muhidrug resistance protein family [ J]. BMC Evol Biol, 2009,9:140.
-
3Danilchanka O, Mailaender C, Niederweis M. Identification of a novel muhidrug efflux pump of Mycobacterium tuberculosis[ J]. Antimicrob Agents Chemother, 2008, 52 (7) :2503.
-
4Pradhan P, Li W, Kaur P. Translational coupling controls expression and function of the DrrAB drug efflux pump [J]. J Mol Biol,2009,385(3):831.
-
5Rao DK, Kaur P. The Q-loop of DrrA is involved in producing the closed conformation of the nucleotide binding domains and in transduction of conformational changes between DrrA and DrrB [ J ]. Biochemistry, 2008,47 ( 9 ) : 3038.
-
6El Sahly HM, Teeter LD, Jost KC Jr, et al. Incidence of moxifloxacin resistance in clinical Mycobacterium tuberculosis isolates in Houston, Texas [J]. J Clin Microbiol,2011,49(8):2942.
-
7Gupta AK, Katoch VM, Chauhan DS, et al. Microarray a- nalysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs [ J ]. Microb Drug Resist, 2010,16 (1):21.
-
8Khazaie K, Bonertz A, Beckhove P. Current developments with peptide-based human tumor vaccines [ J]. Curr Opin Oncol,2009,21 (6) :524.
-
9Larsen MV, Lundegaard C, Lamberth K, et al. Largescale validation of methods for cytotoxic T-lymphocyte epitope prediction [ J ]. BMC Bioinformatics ,2007 ,8 :424.
-
10Ottenhoff TH. Overcoming the global crisis: " yes, we can", but also for TB [ J ]. Eur J Immunol, 2009, 39 ( 8 ) : 2014.
引证文献2
-
1陈飞,高艳锋,朱宇皇,祁元明.结核分枝杆菌耐药相关药物外排抗原HLA-A2限制性细胞毒性T淋巴细胞表位预测[J].郑州大学学报(医学版),2011,46(6):839-841. 被引量:1
-
2车洋,杨天池,平国华,林律.结核分枝杆菌外排泵基因表达与耐药相关性研究[J].中国预防医学杂志,2020,21(11):1205-1209. 被引量:1
二级引证文献2
-
1徐志刚,李德周,陈新宇,段志良,毛嘉媛,文金生.结核分枝杆菌esxN特异性细胞表位的鉴定及其在肺结核诊断中的应用[J].细胞与分子免疫学杂志,2017,33(12):1686-1691. 被引量:1
-
2江丽娜,高丽,王志锐,王秀月,王春花.Sigma因子基因表达与结核分枝杆菌异烟肼耐药关系探讨[J].中国热带医学,2024,24(3):299-303.
-
1孟宪杰.抗结核药物的研究进展[J].河南中医,2014,34(B06):110-111.
-
2毕春霞,闫志勇,王斌.病原微生物临床检验技术进展[J].青岛大学医学院学报,2005,41(4):369-371. 被引量:11
-
3周爽,肖春玲.针对不同靶点新型抗结核药物的药效和药动学性质研究[J].中国抗生素杂志,2013,38(8):561-567. 被引量:3
-
4赵凤芹,王江滨.抗结核药物诱导肝损伤的评价[J].国外医学(呼吸系统分册),2003,23(6):322-324. 被引量:37
-
5叶长根,孙水林,刘亮明.抗结核药物肝毒性危险因素研究进展[J].中华临床医师杂志(电子版),2012,6(6). 被引量:10
-
6侯红波,牛顺平.护理人员在合理使用抗生素中的作用[J].中国药物滥用防治杂志,2010,16(6):364-366.
-
7顾伟娟.避免滥用抗菌药及时补充益生菌[J].家庭用药,2010(4):36-36.
-
8沈震,王明贵.西非埃博拉疫情死灰复燃[J].中国感染与化疗杂志,2017,17(2):223-223. 被引量:1
-
9田玉娜,郑佳.浅谈抗体在抗感染免疫中的作用[J].医学信息(下旬刊),2009(6):241-242. 被引量:1
-
10卢永忠,李群.PCR及其相关技术在结核分枝杆菌检测中应用的研究进展[J].中国消毒学杂志,2003,20(1):36-38.